Selected among over 1000 candidates, Kaiku Health CEO Lauri Sippola has been recognized as one of the 35 young innovators in Europe by the annual MIT Technology Review nomination. Kaiku Health is a digital health company aiming to improve quality of life and reduce costs of healthcare through data science. It is a Debiopharm Innovation Fund portfolio company.
